Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
about
Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 systemCrystal structure of human tryptophanyl-tRNA synthetase catalytic fragment: insights into substrate recognition, tRNA binding, and angiogenesis activityRedirecting cell-type specific cytokine responses with engineered interleukin-4 superkinesThe C-kit receptor-mediated signal transduction and tumor-related diseasesInterleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter.Diversifying selection and functional analysis of interleukin-4 suggests antagonism-driven evolution at receptor-binding interfaces.A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor.Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis.The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis.Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions.Regulation of inflammation by interleukin-4: a review of "alternatives"Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.Evidence of perturbations of the cytokine network in preterm laborMucin overproduction in chronic inflammatory lung disease.First in-depth analysis of the novel Th2-type cytokines in salmonid fish reveals distinct patterns of expression and modulation but overlapping bioactivitiesDevelopment of a human IgG4 bispecific antibody for dual targeting of interleukin-4 (IL-4) and interleukin-13 (IL-13) cytokines.Mechanisms in allergic airway inflammation - lessons from studies in the mouse.Biological implications of glycosaminoglycan interactions with haemopoietic cytokines.Structural biology of shared cytokine receptors.Tannic acid, a higher galloylated pentagalloylglucose, suppresses antigen-specific IgE production by inhibiting ɛ germline transcription induced by STAT6 activation.An atopy-associated polymorphism in the ectodomain of the IL-4R(alpha) chain (V50) regulates the persistence of STAT6 phosphorylationIL-13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function.IL-21 receptor expression in human tendinopathy.Evolution of IL4 and pathogen antagonism.Protective immunity and vaccination against cutaneous leishmaniasis.The potential for genetically altered microglia to influence glioma treatment.STAT6 and lung inflammation.The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells.Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.IL-4 gene expression in adventitial layer (fibrous layer) of hepatic ovine and bovine hydatid cysts.Oxazolone and ethanol induce colitis in non-obese diabetic-severe combined immunodeficiency interleukin-2Rγ(null) mice engrafted with human peripheral blood mononuclear cells.A mouse model for ulcerative colitis based on NOD-scid IL2R γnull mice reconstituted with peripheral blood mononuclear cells from affected individuals.NOD-scid IL2R γnull mice engrafted with human peripheral blood mononuclear cells as a model to test therapeutics targeting human signaling pathways.Dynamics and interaction of interleukin-4 receptor subunits in living cells.Induction of oxazolone-mediated features of atopic dermatitis in NOD-scid IL2Rγ(null) mice engrafted with human peripheral blood mononuclear cellsInterleukin (IL)-4 induces leukocyte infiltration in vivo by an indirect mechanism.Sensing and responding to allergic response cytokines through a genetically encoded circuit.Molecular basis of cytokine signalling--theme and variations.Maximum-likelihood approaches reveal signatures of positive selection in IL genes in mammals.
P2860
Q24310081-BA7BBF9F-7F56-4E24-9508-96F8BCB2F123Q27642730-2DCF7443-4D07-4ACE-9634-443A7777B978Q27674753-30B95E93-4765-4F70-8FEE-A7950FC28B9BQ30419298-6E990893-8987-474C-AA03-7BBD99509D10Q30478469-3F5D6324-7C94-4BBE-9883-58CF94C5DA7DQ30986346-4C9B232B-72B1-4EAA-B465-3BE6F122197EQ33241201-2485BD6D-91AF-4DBB-904E-0017D9AC347EQ33384724-CCE1C2F1-3389-4605-AA1B-FF2A49CC114BQ33614316-DE4497E4-C41B-4AD1-95E1-4B96B764426DQ34321147-D1CB9EAD-A4E7-4A8B-A55D-C584BCD74013Q34619781-33073A39-97AB-4362-83D9-3669CA6F34DBQ36232198-7A66E7DF-44A7-4372-B7E1-C9BF420F3914Q36296416-485FF337-166B-464D-AEB7-579B505F723EQ36372845-9DE9C04C-0251-433A-9F0D-E5B8C1AF107CQ36597355-81B60CF9-9608-4BCE-886B-DD2889243336Q36998130-22FDC714-6FAC-49ED-8A6B-598DEADD8877Q37168393-98982066-A8E2-4084-90DA-ECC46BC1E360Q37173306-224F2A65-ACB9-443F-B9F6-145D127F3DADQ37216313-9DD20D55-339E-4C32-AD59-2F9B30A40959Q37279324-B4689BBF-E690-4F05-98B5-67481760EB46Q37289643-E5B474C6-80D7-402E-B0BC-0412DB5918B8Q37362151-4FFA480C-F8D6-4665-9A2E-D385DC098B0AQ37647886-D0CA89B6-E8C4-418F-BEE6-C05512A4C1E0Q37686734-1A5D58CF-177D-4D9A-A2B2-4D5E8E22A8E8Q37887778-14E7A0F7-881C-439F-8D30-AC83A35DB8A8Q38015852-D334F868-022F-4C5A-B7B6-BA9B58BA23BFQ38139120-445643F6-C773-40AA-B462-D4D40485DD96Q38177817-97579EA1-60EB-43A9-92AC-7DA49CEADEA4Q38224933-611FD3C6-7080-4233-A0C2-07B70F421069Q38948633-94EF54DA-A5EE-46FD-BBA0-1831B496E275Q38976662-29EAB42A-230D-4DD3-9559-FA8B4DD396D8Q39168573-06CFDAAE-8CE4-499C-BB06-F444C50F37D7Q41285453-64EEFFE0-882E-4844-B7C6-BB42F289ACA2Q41768955-8CCD10C4-8D9F-44EF-A3B8-467335A8382FQ41903204-7F14652D-3C5A-4A97-858E-C24DB2051ED2Q42426996-418BEF7D-9E29-49C2-BF2C-9F684E25F596Q42553363-B1E4831D-A712-4811-B29E-20BEBA7FF820Q42645824-EC9ABEC5-4D5A-4C40-A968-3357A69C55DEQ43232912-ED22DDF5-2E0E-4735-A063-B218561349A1Q44277897-8D92A526-2242-4DF8-B6C3-4673B8904312
P2860
Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
@ast
Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
@en
Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
@nl
type
label
Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
@ast
Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
@en
Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
@nl
prefLabel
Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
@ast
Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
@en
Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
@nl
P2093
P1476
Structure, binding, and antagonists in the IL-4/IL-13 receptor system
@en
P2093
Jin-Li Zhang
Thomas D Mueller
Walter Sebald
P304
P356
10.1016/S0167-4889(02)00318-X
P407
P577
2002-11-01T00:00:00Z